Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is evaluating fecal microbiota transplant in combination with standard first-line therapy for initially unresectable colorectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Unresectable Colorectal Cancer, Colorectal Cancer (Locally Advanced or Metastatic) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING